Firm
The tie-up could result in the firm’s German and France-based teams, which both have strong UPC expertise, becoming independent
Price hikes at ‘big law’ firms are pushing some clients toward boutiques that offer predictable fees, specialised expertise, and a model built around prioritising IP
Koen Bijvank of Brinkhof and Johannes Heselberger of Bardehle Pagenberg discuss the Amgen v Sanofi case and why it will be cited frequently
King & Wood Mallesons will break into two entities, 14 years after a merger between a Chinese and an Australian firm created the combined outfit
Recently published Special Focus articles
Recently published Special Focus articles
-
Sponsored by Maiwald Intellectual PropertyKerstin Wolff and Tobias Matschke of Maiwald Intellectual Property examine a landmark Unified Patent Court decision on second medical use claims and compare it with Germany’s established approach to ‘skinny label’ products
-
Sponsored by Spoor & FisherHerman Blignaut of Spoor & Fisher South Africa addresses whether the act extends to intellectual property rights and reassures brand owners that constitutional protection remains intact
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos analyses a ruling confirming that patent claims must be interpreted with reference to the description and drawings
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Anita Rawat of RNA, Technology and IP Attorneys address the main questions concerning India’s regulation of greenwashing across advertising, financial products, and the food sector
-
Sponsored by Wanhuida Intellectual PropertyAs an AstraZeneca patent survives a tenth invalidation challenge in China, Jianhui Li of Wanhuida Intellectual Property considers the implications for generic drug makers and the pharmaceutical industry
-
Sponsored by Tilleke & GibbinsSuebsiri Taweepon of Tilleke & Gibbins highlights a critical issue in Thailand’s copyright regime while examining the legal uncertainties, licensing burdens, and data-scraping risks in AI development